Category: Autoimmune health

In placebo-controlled trials for rheumatologic indications, approximately 37% of patients treated with Enbrel developed injection site reactions [1.2.2]. This article explores what is the most commonly reported side effect of Enbrel and provides further details on other potential reactions.

Immunosuppressive therapies are vital for managing autoimmune diseases and preventing organ transplant rejection [1.4.6]. However, not everyone is a suitable candidate. Understanding who cannot take immunosuppressants is crucial for patient safety and treatment efficacy.

Studies suggest that between 12.2% and 18.1% of people who receive oral glucocorticoids like prednisone become long-term users [1.5.2]. For these individuals, the critical question becomes: **what can you take long term instead of prednisone?**

For up to 90% of patients with lupus, Plaquenil (hydroxychloroquine) therapy has been shown to reduce a variety of symptoms [1.2.1]. A significant question for many is: does Plaquenil improve fatigue, a common and debilitating symptom of autoimmune diseases?

In a study of lupus patients, hydroxychloroquine use was associated with a significant reduction in mortality and organ damage [1.8.4]. But despite its benefits, many wonder: **is Plaquenil hard on the body?** While generally well-tolerated, it carries risks that require careful management [1.7.1].